Importantly, depletion of mutant p53 impairs the HIF1-mediated up-regulation of various ECM components, including type VIIa1 collagen and laminin-γ2, and reduces the tumorigenic potential of NSCLC cells in vitro and in mouse models in vivo [163]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.